Tracking the ANNX option chain helps you see every strike and expiry on Annexon Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Annexon Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ANNX options activity at a glance. Use our scanner to monitor the ANNX option chain in real time and filter for the ANNX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ANNX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ANNX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ANNX stock options are being actively traded and where they are not.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis.
The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Annexon Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ANNX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ANNX stock options — let the full option chain come to you, pre-filtered and ready to trade.
